Adult Congenital Heart Disease
Sanger Heart & Vascular Institute's nationally recognized adult congenital heart disease (ACHD) program helps the growing number of ACHD patients transition to adult care and achieve a higher quality of life, long-term.
National Presentations
We are shaping the direction of ACHD care by participating in key national meetings and symposia:
- Sanger’s ACHD program director chaired the South Atlantic Cardiovascular Society symposium.
- Our director also presented on infective endocarditis and the Mediterranean diet at the Adult Congenital Heart Association’s national conference.
- We presented a case study at the American College of Cardiology’s annual meeting. The case study was on utilizing cardiac MRI to evaluate acute, severe pulmonic insufficiency in pulmonic valve infective endocarditis.
- At the American Heart Association’s scientific sessions, we presented a case study on an adult living with undiagnosed total anomalous pulmonary venous return.
Awards and Recognition
-
2022 Certified Clinic
-
Sanger's Marfan Syndrome and Genetic Aortopathy Clinic was recognized by the Marfan Foundation as a coordinated clinic in 2022.
-
Sanger physicians provided care at Atrium Health Levine Children's Hospital. In 2022, we were nationally ranked as a top 25 Pediatric Cardiology and Heart Surgery Program by U.S. News & World Report.
Advanced ACHD Care
-
250
New Patients
2022
Internal Data,
YTD August 2022 Annualized -
38
Cath Lab Procedures
2022
Internal Data,
January - September 2022 -
1,500
Clinic Visits
2022
Internal Data,
YTD August 2022 Annualized -
11,280
Clinic Visits
Since 2014
Internal Data,
2014 - YTD August 2022 Annualized -
275
Surgeries
Since 2014
Internal Data,
September 2014 - August 2022 -
1.45%
In-hospital Mortality Rate
Since 2014
Internal Data,
September 2014 - August 2022